{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:11Z","timestamp":1786997891422,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.vaccine.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T22:01:26Z","timestamp":1502316086000},"page":"5081-5088","source":"Crossref","is-referenced-by-count":58,"title":["The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26\u201327 October 2016, Oxford, UK"],"prefix":"10.1016","volume":"35","author":[{"given":"James E.","family":"Meiring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malick","family":"Gibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buddha","family":"Basnyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adwoa D.","family":"Bentsi-Enchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Darton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashmira","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Dougan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melita A.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Heyderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Hombach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Kotloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Luby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadrevu Krishna","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Marfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia E.","family":"Pitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Salisbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.08.001_b0005","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.08.001_b0010","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.7189\/jogh.01.010401","article-title":"Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010","volume":"2","author":"Buckle","year":"2012","journal-title":"J Glob Health"},{"key":"10.1016\/j.vaccine.2017.08.001_b0015","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.vaccine.2017.08.001_b0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12879-016-1351-3","article-title":"Revisiting typhoid fever surveillance in low and middle income countries: lessons from systematic literature review of population-based longitudinal studies","volume":"16","author":"Mogasale","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0025","doi-asserted-by":"crossref","first-page":"e0005376","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: a meta-regression approach","volume":"11","author":"Antill\u00f3n","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/infdis\/7.4.489","article-title":"On the Mills-Reincke Phenomenon and Hazen s theorem concerning the decrease in mortality from diseases other than typhoid fever following the purification of public water-supplies","volume":"7","author":"Sedgwick","year":"1910","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1353\/dem.2005.0002","article-title":"The role of public health improvements in health advances: the twentieth-century United States","volume":"42","author":"Cutler","year":"2005","journal-title":"Demography"},{"key":"10.1016\/j.vaccine.2017.08.001_b0040","unstructured":"UN-Water: WHO\/UNICEF Joint Monitoring Programme for Water Supply and Sanitation (JMP). <http:\/\/www.unwater.org\/publications\/jmp\/en\/> [accessed March 31, 2017]."},{"key":"10.1016\/j.vaccine.2017.08.001_b0045","unstructured":"WHO|8 February 2008, vol. 83, 6. WHO; 2012. p. 49\u201360."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.08.001_b0050","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/cid\/civ976","article-title":"Challenges and opportunities for typhoid fever control: a call for coordinated action","volume":"62","author":"Steele","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0055","unstructured":"WHO|Expert consultation to review evidence in support of the use of typhoid conjugate vaccines. WHO; 2014. <http:\/\/www.who.int\/immunization\/research\/meetings_workshops\/typhoidvaccines_july14\/en\/> [accessed March 31, 2017]."},{"key":"10.1016\/j.vaccine.2017.08.001_b0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","article-title":"Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph\u2122) in Indian children: school based cluster randomized study","volume":"12","author":"Mitra","year":"2016","journal-title":"Hum Vaccin Immun"},{"key":"10.1016\/j.vaccine.2017.08.001_b0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0070","unstructured":"WHO|SAGE Working Group on Typhoid Vaccines (established March 2016). WHO; 2016."},{"key":"10.1016\/j.vaccine.2017.08.001_b0075","unstructured":"Typhoid Vaccine Acceleration Consortium; 2017. <http:\/\/www.medschool.umaryland.edu\/CVD\/Projects\/Typhoid-Vaccine-Acceleration-Consortium-TyVAC\/>. doi: <http:\/\/www.medschool.umaryland.edu\/CVD\/Projects\/Typhoid-Vaccine-Acceleration-Consortium-TyVAC\/>."},{"key":"10.1016\/j.vaccine.2017.08.001_b0080","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ng.3281","article-title":"Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events","volume":"47","author":"Wong","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2017.08.001_b0085","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.vaccine.2004.11.044","article-title":"Policymakers\u2019 views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia","volume":"23","author":"DeRoeck","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.001_b0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12941-016-0147-z","article-title":"What proportion of Salmonella Typhi cases are detected by blood culture? A systematic literature review","volume":"15","author":"Mogasale","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.vaccine.2017.08.001_b0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends in typhoid and paratyphoid Fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.06.039818","article-title":"A study of typhoid fever in five Asian countries: disease burden and implications for controls","volume":"86","author":"Ochiai","year":"2008","journal-title":"Bull World Heal Organ"},{"key":"10.1016\/j.vaccine.2017.08.001_b0105","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3201\/eid1102.040422","article-title":"Bacteremic Typhoid Fever in Children in an Urban Slum, Bangladesh","volume":"11","author":"Brooks","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijid.2005.03.010","article-title":"Typhoid fever in children: some epidemiological considerations from Karachi, Pakistan","volume":"10","author":"Siddiqui","year":"2006","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3855\/jidc.2629","article-title":"Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study","volume":"7","author":"Punjabi","year":"2013","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.vaccine.2017.08.001_b0120","doi-asserted-by":"crossref","first-page":"e2391","DOI":"10.1371\/journal.pntd.0002391","article-title":"Differential epidemiology of Salmonella Typhi and Paratyphi A in Kathmandu, Nepal: a matched case control investigation in a highly endemic enteric fever setting","volume":"7","author":"Karkey","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1473-3099(10)70072-4","article-title":"Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis","volume":"10","author":"Reddy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0130","doi-asserted-by":"crossref","first-page":"e29119","DOI":"10.1371\/journal.pone.0029119","article-title":"Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa","volume":"7","author":"Breiman","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.08.001_b0135","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/cid\/civ693","article-title":"The Typhoid Fever Surveillance in Africa Program (TSAP): clinical, diagnostic, and epidemiological methodologies","volume":"62","author":"von Kalckreuth","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0140","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.vaccine.2017.08.001_b0145","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/cid\/civ787","article-title":"Variations of invasive Salmonella infections by population size in Asante Akim North Municipal, Ghana","volume":"62","author":"Cruz Espinoza","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0150","unstructured":"Kallenberg J. Gavi\u2019s vaccine investment strategy. <http:\/\/www.gavi.org> [accessed Dec 2, 2016]."},{"key":"10.1016\/j.vaccine.2017.08.001_b0155","doi-asserted-by":"crossref","first-page":"e016283","DOI":"10.1136\/bmjopen-2017-016283","article-title":"The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys","volume":"7","author":"Darton","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2017.08.001_b0160","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.08.001_b0165","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Mai Ngoc","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.08.001_b0170","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1586\/14760584.2013.845529","article-title":"Development of Vi conjugate \u2013 a new generation of typhoid vaccine","volume":"12","author":"Szu","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.08.001_b0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"lmmunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0180","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.08.001_b0185","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1016\/j.vaccine.2012.06.015","article-title":"Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi","volume":"30","author":"Khan","year":"2012","journal-title":"Pakistan. Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.001_b0190","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.08.001_b0195","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(96)09267-7","article-title":"Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants","volume":"349","author":"Mulholland","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.08.001_b0200","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2002","journal-title":"Lancet (London, England)"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.08.001_b0205","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1086\/518144","article-title":"The use of typhoid vaccines in Asia: the DOMI experience","volume":"45","author":"Ochiai","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0210","doi-asserted-by":"crossref","first-page":"h391","DOI":"10.1136\/bmj.h391","article-title":"The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting","volume":"350","author":"Hemming","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2017.08.001_b0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13063-015-0839-2","article-title":"Stepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014","volume":"16","author":"Beard","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.vaccine.2017.08.001_b0220","first-page":"5782","article-title":"The gambia hepatitis study group","volume":"47","author":"The Gambia Hepatitis Intervention Study","year":"1987","journal-title":"Can Res"},{"key":"10.1016\/j.vaccine.2017.08.001_b0225","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jclinepi.2010.12.003","article-title":"Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation","volume":"64","author":"Mdege","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2017.08.001_b0230","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3201\/eid2201.151410","article-title":"Effectiveness of ring vaccination as control strategy for ebola virus disease","volume":"22","author":"Kucharski","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0235","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.08.001_b0240","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/tmi.12367","article-title":"Typhoid fever in Fiji: a reversible plague?","volume":"19","author":"Thompson","year":"2014","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2017.08.001_b0245","doi-asserted-by":"crossref","first-page":"e2642","DOI":"10.1371\/journal.pntd.0002642","article-title":"Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study","volume":"8","author":"Pitzer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.08.001_b0250","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.110008","article-title":"Combined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmission","volume":"1","author":"Baker","year":"2011","journal-title":"Open Biol"},{"key":"10.1016\/j.vaccine.2017.08.001_b0255","doi-asserted-by":"crossref","first-page":"e0127962","DOI":"10.1371\/journal.pone.0127962","article-title":"Etiology of severe febrile illness in low- and middle-income countries: a systematic review","volume":"10","author":"Prasad","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.08.001_b0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093784","article-title":"Case fatality rate and length of hospital stay among patients with typhoid intestinal perforation in developing countries: a systematic literature review","volume":"9","author":"Mogasale","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.08.001_b0265","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(13)61682-7","article-title":"Use of vaccines as probes to define disease burden","volume":"383","author":"Feikin","year":"2014","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17310654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17310654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T12:56:07Z","timestamp":1535460967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17310654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":53,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0264410X17310654"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}